Dental Tribune USA

Geistlich Biomaterials enters new partnership with Osteogenics Biomedical

Geistlich Biomaterials has announced an expansion of its portfolio of regenerative and complementary products through a new distribution partnership with Osteogenics Biomedical.

“Adding the Reinforced PTFE Mesh, RPM, to our product offering enables Geistlich Biomaterials to provide a unique solution to the difficult challenge of horizontal and vertical ridge augmentation,” said Greg Bosch, CEO, Geistlich Pharma North America. “The product aligns nicely to our core values of offering clinicians scientific and clinically tested regenerative products.”

Osteogenics Biomedical co-developed RPM with Prof. Dr. Istvan Urban, which was released into the market in 2019. The new RPM technology combines the benefits of a stable scaffold and a PTFE barrier membrane, while allowing optimal supply of the bone graft through vascularization from the periosteum to obtain vital bone.

To learn more about RPM, visit

Vertical ridge augmentation with RPM

Reinforced PTFE Mesh, RPM, can be easily trimmed, adapted and fixed with pins. RPM offers high stability and the secluded space can be augmented with a mixture of Geistlich Bio-Oss and autologous bone. Geistlich Bio-Oss provides long-term volume stability[3] and autologous bone contains the required osteoinductive properties for vertical augmentation.[4] The autologous particulate bone graft can be harvested from the mandibular ramus using a bone scraper device,[3,5] such as Micross.

PTFE membranes have a long-standing history as barrier membranes and are highly biocompatible.[1] Collagen membranes, such as Geistlich Bio-Gide, have been shown beneficial for uneventful soft tissue healing[5,6] in guided bone regeneration (GBR) procedures resulting in low complication rates.[5] Thus, potential exposures can be anticipated by covering RPM with Geistlich Bio-Gide to obtain better soft tissue healing.[5,6] Moreover, both Geistlich Bio-Gide and RPM follow the concept of biofunctional membranes that allow nutrition and early vascularization of the graft.

As for all augmentative procedures, soft tissue management is key.[2,7] This especially comprises:

  • Preparation of soft tissues before, during, and after treatment to increase mucogingival thickness and keratinized tissue width.
  • Elevation of a full-thickness remote or papilla preservation flap.
  • Periosteal release to advance flap to achieve tension-free closure.
  • Primary soft tissue closure by horizontal mattress and single interrupted sutures.


  1. Elgali I, et al: Eur J Oral Sci 2017; 125 (5), 315-337.
  2. Urban IA, et al.: J Periodontics Restorative Dent 2017; 37(5):639-645 (clinical study) – review format of this reference.
  3. Buser D et al., J Dent Res. 2013 Dec;92(12 Suppl):176S–82S (Clinical study).
  4. Urban IA et al., Int J Periodontics Restorative Dent 2015, 35(5):613-623 (clinical study) – review format of this reference.
  5. Becker J et al. Clin Oral Implants Res. 2009; 20(7):742-749. (Clinical study).
  6. Tal H et al. Clin Oral Implants Res. 2008; 19(3): 295-302. (Clinical study).
  7. Urban IA, et al Int J Periodontics Restorative Dent 2016, 36(3):329-337 (clinical study) review format of this reference.

(Source: Geistlich Biomaterials)

© 2021 - All rights reserved - Dental Tribune International